CTRI/2020/09/028092Not yet recruiting未知
Analysis of Choroidal thickness in children with unilateral amblyopia using swept source optical coherence tomography and their changes following occlusion therapy.
Sankara Eye Hospital Shimoga0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- 未知
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1. Children with unilateral strabismic and anisometropic amblyopia will be included in group 1.
- •2. Uncorrected visual acuity of LogMAR 0.00 in both eyes will be included in group 2.
- •3. Children with normal neurological, ocular and systemic examination.
- •4. Children who will be willing for follow up.
Exclusion Criteria
- •1.Previous history of Spectacle wear/ Occlusion therapy/ Ocular surgery.
- •2.Refractive error correction >6D Spherical power and >3D Cylindrical power.
- •3. Presence of Nystagmus/ Hearing impairment/ Development delay.
- •4. Not compliant for Spectacle wear and/ or occlusion therapy.
- •5. Children who will have poor fixation co-operation for SS-OCT test due to poor vision or lower age.
- •6. Children who will come for <2 follow up.
Investigators
Similar Trials
Not yet recruiting
Not Applicable
Estimation of Choroidal thickness in healthy and Diabetic individuals by SD-OCT EDICTRI/2022/01/039177Danalakshmi
Completed
Not Applicable
Choroidal thickness in patients with central serous chorioretinopathy (CSC) and myopia10047060Central Serous ChorioretinopathyNL-OMON45973Oogziekenhuis Rotterdam30
Recruiting
Not Applicable
Comparison of subfoveal choroidal thickness in normal eyes of Japanese between SS-OCT and SD-OCT devices.chorioretinal lesionJPRN-UMIN000009073Tsukazaki hospital100
Completed
Not Applicable
ongitudinal changes of choroidal thickness in healthy pediatric individuals using swept-source optical coherence tomography(SS-OCT)healthy childrenJPRN-UMIN000027848Saneikai Tsukazaki Hospital60
Not yet recruiting
Phase 4
A clinical trial to study the effects of Aflibercept in patients with type 2 diabetes mellitus with reduced vision.Diabetic Macular EdemaJPRN-UMIN000051561MMU Mullana Ambala100